Roivant Sciences (ROIV) Non Operating Income (2021 - 2022)
Roivant Sciences' (ROIV) quarterly Non Operating Income came in at $18.1 million in Q4 2022, up 537.6% YoY from $2.8 million in Q4 2021, and up 404.12% on a QoQ basis from -$5.9 million in Q3 2022.
Roivant Sciences (ROIV) Non Operating Income (2021 - 2022) Analysis & Trends
Roivant Sciences (ROIV) has 2 years of Non Operating Income data on file, last reported at $18.1 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -139.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 12.40 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -51.63 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -53.64 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 18.10 Mn |
| Sep 30, 2022 | -5.95 Mn |
| Dec 31, 2021 | 2.84 Mn |
| Sep 30, 2021 | -2.20 Mn |